#drug-manufacturing
(5 articles)US Pharma's Chinese Supply Chain Dependency: A Critical Risk
The US pharmaceutical industry faces significant structural vulnerability through its dependence on Chinese supply chains for active pharmaceutical ingredients (APIs), intermediates, and manufacturing
Generic Drug Tariffs: Trump Plan Aims to Reshore US Production
The Trump administration has proposed targeted tariffs on generic drug imports as part of a broader industrial policy to reshore pharmaceutical manufacturing capacity to the United States. While the g
Pharmaceutical Manufacturers Face Critical Production Challenges
Pharmaceutical manufacturers face mounting operational pressures across multiple dimensions of their supply chains. The industry confronts a complex landscape of challenges including stringent regulat
Trump's Generic Drug Tariffs Threaten Medicine Prices and Supply
The Trump administration's proposal to impose tariffs on generic drugs represents a significant structural shift in how the US pharmaceutical supply chain operates. Generic drugs, which represent roug
100 Essential US Medicines Face Hidden Supply Chain Risks
A comprehensive CIDRAP analysis has identified hidden supply chain vulnerabilities affecting approximately 100 essential medicines in the United States. These risks stem from single-source dependencie